Santa Cruz Biotechnology provides a broad selection of ADH6 monoclonal antibodies for research focused on understanding alcohol dehydrogenase 6 (ADH6) in various biological processes. ADH6 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ADH6 is an essential enzyme involved in the metabolism of alcohols and plays a significant role in the detoxification of ethanol and other substrates. Expression of ADH6 is particularly notable in the liver and has implications in alcohol metabolism and potential associations with alcohol-related disorders. Research focusing on ADH6 can provide valuable insights into metabolic pathways and contribute to the development of therapeutic strategies for alcohol-related conditions. ADH6 monoclonal antibodies enable precise detection and characterization of ADH6 expression patterns across different tissues and experimental conditions. Investigating ADH6 function and regulation helps advance understanding of cellular responses to various metabolic challenges. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of alcohol metabolism and its impact on human health.